Дыхательная система при ожирении
Антиплагиат
Не указан
Размещена
4 Авг 2015
в 19:09
ВУЗ
Не указан
Курс
Не указан
Стоимость
250 ₽
Демо-файлы
4
2015-08-04 19-09-08 Скриншот экрана.png
2015-08-04 19-09-00 Скриншот экрана.png
2015-08-04 19-08-51 Скриншот экрана.png
2015-08-04 19-08-46 Скриншот экрана.png
Файлы работы
1
Каждая работа проверяется на плагиат, на момент публикации
уникальность составляет не менее 40% по системе проверки eTXT.
Эссе Дыхательная система при ожирении
Описание
Известно, что патологию органов дыхания имеют около 35% пациентов с ожирением. Лица с избытком веса часто жалуются на одышку при нагрузке, механизм которой выяснен не до конца
Список литературы
1. Aaron SD, Vandemheen K, Fergusson D et al. The Canadian Optimal Therapy of COPD Trial: Design, organization and patient recruitment. Can Respir J 2004; 11 (8): 581–5.
2. Aim C.W., Kim C.S., Nam J.H., Kim H.J. et al. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control. - Clin Endocrinol (Oxf). 2006, Apr; 64 (4): 444-9.
3. Alan R. Schwartz, Susheel P. Patil, Alison M. Laffan, Vsevolod Polotsky, Hartmut Schneider, and
4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James PT, Loria CM, Smith Jr SC. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.
5. Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss Am J Cardiol 1997;80:736-740
6. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome Am J Med Sci 2001;321:225-236.
7. Anker S, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study Lancet 2003;361:1077-1083.
8. Bady E, Achkar A, Pascal S, et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55:934–9.
9. Barrett PHR, Watts GF. Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effect of nutritional interventions. Curr Opin Lipidol 2003; 14: 61–68.
10. Bercalp B., Cesur V., Corapciogolu D et al. Obesity and left ventricular diastolic dysfunction. Int J Cardiol, 1995; 52: 23-26.
11. Brinkworth G.D., Noakes M., Buckley J.D., Clifton P.M. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome. Am Heart J. 2006, Oct; 152(4):693: 1-6.
12. Bua J. , Prescott E., Schack-Nielsen L., Petersen L., Godtfredsen NS, Sørensen TIA, et al. Weight history from birth through childhood and youth in relation to adult lung function, in Danish juvenile obese and non-obese men. Int J Obes (Lond) 2005;29:1055-62.
13. Busetto L, Enzi G, Inelmen EM, Costa G, Negrin V, Sergi G, Vianello A. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. // Chest. 2005 Aug;128(2):618-23.
14. Carroll S, Dudfiled M. What is the relationship between exercise and metabolic abnormalities? Sports Med 2004; 34: 371–418.
15. Chakko S, Mayor M, Allison, MD, Kessler KM, Materson BJ, Myerburg RJ. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity Am J Cardiol 1991;68:95-98.
16. Coromilas J. Obesity and atrial fibrillation. Is one epidemic feeding the other? J. A. M. A. 2004; 292: 2519-2520.
17. De Lorenzo A., Maiolo С, Bruno E., Alessandrini M., Napolitano B., De Padova A., Di Daniele N. Dual energy X-ray absorptiometry analysis of body composition in patients affected by OSAS. / Eur Arch Otorhinolaryngol 2009 (266): 1285-1290.
18. Enzi G., Biondetti P. R., Fiore D., Mazzoleni F. Computed tomography of deep fat masses in multiple summetrical lipomatosis. Radiology. 1982; Jul; 144 (1): 121-124.
19. Ferretti A, Giampiccolo P, Cavalli A, Milic-Emili J, Tantucci C. Expiratory flow limitation and orthopnea in massively obese subjects. / Chest. 2001 May;119(5):1401-8.
20. Fonarow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry Am Heart J 2007;153:74-81
21. Fonseca V. The metabolic syndrome, hyperlidemia, and insulin resistance. Clin Cornerstone 2005; 7: 61–72.
22. Ford E.S. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005;115:897-909.
23. Fraley M.A., Birchem J.A., Senlcottaiyan N., Alpert M.A. Obesity and electrocardiogram. Obesity reviews; 6: 275-281.
24. Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR, and QTc intervals Am J Cardiol 1995;75:956-959
25. Garaulet M., Perez-Llamas F., Zamora S., Terar F. J. Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome. J. Physiol Biochem; 2002, Sep; 58(3); 151-160.
26. Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Grossman E. Myocardial contractility and left ventricular function in obese patients with essential hypertension Am J Cardiol 1988;62:594-597.
27. Gelber RP, Gaziano JM, Oraw EJ, et al. Measures of obesity and cardiovascular risk among men and women J Am Coll Cardiol 2008;52:605-615.
28.
2. Aim C.W., Kim C.S., Nam J.H., Kim H.J. et al. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control. - Clin Endocrinol (Oxf). 2006, Apr; 64 (4): 444-9.
3. Alan R. Schwartz, Susheel P. Patil, Alison M. Laffan, Vsevolod Polotsky, Hartmut Schneider, and
4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James PT, Loria CM, Smith Jr SC. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.
5. Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss Am J Cardiol 1997;80:736-740
6. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome Am J Med Sci 2001;321:225-236.
7. Anker S, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study Lancet 2003;361:1077-1083.
8. Bady E, Achkar A, Pascal S, et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55:934–9.
9. Barrett PHR, Watts GF. Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effect of nutritional interventions. Curr Opin Lipidol 2003; 14: 61–68.
10. Bercalp B., Cesur V., Corapciogolu D et al. Obesity and left ventricular diastolic dysfunction. Int J Cardiol, 1995; 52: 23-26.
11. Brinkworth G.D., Noakes M., Buckley J.D., Clifton P.M. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome. Am Heart J. 2006, Oct; 152(4):693: 1-6.
12. Bua J. , Prescott E., Schack-Nielsen L., Petersen L., Godtfredsen NS, Sørensen TIA, et al. Weight history from birth through childhood and youth in relation to adult lung function, in Danish juvenile obese and non-obese men. Int J Obes (Lond) 2005;29:1055-62.
13. Busetto L, Enzi G, Inelmen EM, Costa G, Negrin V, Sergi G, Vianello A. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. // Chest. 2005 Aug;128(2):618-23.
14. Carroll S, Dudfiled M. What is the relationship between exercise and metabolic abnormalities? Sports Med 2004; 34: 371–418.
15. Chakko S, Mayor M, Allison, MD, Kessler KM, Materson BJ, Myerburg RJ. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity Am J Cardiol 1991;68:95-98.
16. Coromilas J. Obesity and atrial fibrillation. Is one epidemic feeding the other? J. A. M. A. 2004; 292: 2519-2520.
17. De Lorenzo A., Maiolo С, Bruno E., Alessandrini M., Napolitano B., De Padova A., Di Daniele N. Dual energy X-ray absorptiometry analysis of body composition in patients affected by OSAS. / Eur Arch Otorhinolaryngol 2009 (266): 1285-1290.
18. Enzi G., Biondetti P. R., Fiore D., Mazzoleni F. Computed tomography of deep fat masses in multiple summetrical lipomatosis. Radiology. 1982; Jul; 144 (1): 121-124.
19. Ferretti A, Giampiccolo P, Cavalli A, Milic-Emili J, Tantucci C. Expiratory flow limitation and orthopnea in massively obese subjects. / Chest. 2001 May;119(5):1401-8.
20. Fonarow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry Am Heart J 2007;153:74-81
21. Fonseca V. The metabolic syndrome, hyperlidemia, and insulin resistance. Clin Cornerstone 2005; 7: 61–72.
22. Ford E.S. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005;115:897-909.
23. Fraley M.A., Birchem J.A., Senlcottaiyan N., Alpert M.A. Obesity and electrocardiogram. Obesity reviews; 6: 275-281.
24. Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR, and QTc intervals Am J Cardiol 1995;75:956-959
25. Garaulet M., Perez-Llamas F., Zamora S., Terar F. J. Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome. J. Physiol Biochem; 2002, Sep; 58(3); 151-160.
26. Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Grossman E. Myocardial contractility and left ventricular function in obese patients with essential hypertension Am J Cardiol 1988;62:594-597.
27. Gelber RP, Gaziano JM, Oraw EJ, et al. Measures of obesity and cardiovascular risk among men and women J Am Coll Cardiol 2008;52:605-615.
28.
Вам подходит эта работа?
Похожие работы
400 ₽
Другие работы автора
2 500 ₽
Предыдущая работа
Следующая работа